Skip Navigation

Archive-It

Facebook iconTwitter iconWordpress icon

National Library of Medicine

Archive-It Partner Since: Mar, 2009

Organization Type: National Institutions

Organization URL: http://www.nlm.nih.gov/   

Description:

The National Library of Medicine (NLM), the world's largest medical library and a component of the National Institutes of Health, collects, preserves, and makes available to the public information about health, medicine, and the biomedical sciences. To continue fulfilling this mission, NLM is collecting and archiving related Web content, which also serves to document the histories of health and medicine. For questions about our web archiving program contact us at nlmwebcollecting@nlm.nih.gov.

Page 1 of 1 (27 Total Results)

Title: Épidémie d’Ébola de 2014 en Afrique occidentale

URL: http://www.fda.gov/EmergencyPreparedness/Counterterrorism/MedicalCountermeasures/ucm411646.htm

Collection: Global Health Events web archive

Description: Page on the US Food and Drug Administration (USDA) website featuring the most recent updates on the Ebola response at the Food and Drug Administration (FDA) in French. The FDA is working to expedite the development and availability of medical products, including treatments, vaccines, diagnostic tests, and personal protective equipment, that may help to end the Ebola epidemic in West Africa.

Loading Wayback Capture Info...

Loading video data...

Title: Why You Should Not Use Ivermectin to Treat or Prevent COVID-19 | FDA

URL: https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19

Collection: Global Health Events web archive

Description: Website from U.S. Food and Drug Administration regarding the use of Ivermectin to treat COVID-19

Loading Wayback Capture Info...

Loading video data...

Title: Vaccine Adverse Event Reporting System (VAERS)

URL: https://vaers.hhs.gov/

Collection: Global Health Events web archive

Description: Website for Vaccine Adverse Event Reporting System regarding reactions to the vaccine, links to resources, ways to reports, submitting follow-up information, helpful links, learning tools and vaccine safety information

Loading Wayback Capture Info...

Loading video data...

Title: Regeneron Letter of Authorization, February 25, 2021

URL: https://www.fda.gov/media/145610/download

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Title: Press Announcements | FDA

URL: https://www.fda.gov/news-events/fda-newsroom/press-announcements/

Collection: Global Health Events web archive

Description: Website from U.S. Food and Drug Administration, up to date press announcements

Loading Wayback Capture Info...

Loading video data...

Title: Pfizer-BioNTech COVID-19 Vaccine Frequently Asked Questions | FDA

URL: https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/pfizer-biontech-covid-19-vaccine-frequently-asked-questions

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Title: Letter to Eli Lilly & Company from the US Food & Drug Administration Re: Emergency Use Authorization 090

URL: https://www.fda.gov/media/143602/download

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Title: Fact Sheet for Healthcare Providers: Emergency Use of the of the Lungpacer Diaphragm Pacing Therapy System During the COVID-19 Pandemic

URL: https://www.fda.gov/media/136990/download

Collection: Global Health Events web archive

Description: This two-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Lungpacer Diaphragm Pacing Therapy System during the COVID-19 pandemic, which received an Emergency Use Authorization from the Food and Drug Administration on April 3, 2020. It is for use with patients with COVID-19 and other illnesses or conditions that require mechanical ventilation, who are not spontaneously breathing, and are expected to require prolonged ventilation.

Loading Wayback Capture Info...

Loading video data...

Title: Fact Sheet for Healthcare Providers: Emergency Use of the oXiris Set Device for COVID-19

URL: https://www.fda.gov/media/137265/download

Collection: Global Health Events web archive

Description: This two-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the oXiris Set device for the reduction of pro-inflammatory mediators, which received an Emergency Use Authorization from the Food and Drug Administration on April 22, 2020. The oXiris Set device is authorized for emergency use to treat patients 18 years of age or older with confirmed COVID-19 admitted to the intensive care unit (ICU) with confirmed or imminent respiratory failure in need of blood purification, including use in continuous renal replacement therapy.

Loading Wayback Capture Info...

Loading video data...

Title: Fact Sheet for Healthcare Providers: Emergency Use of the TransAeris® Diaphragm Pacing System During the COVID-19 Pandemic

URL: https://www.fda.gov/media/136936/download

Collection: Global Health Events web archive

Description: This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the TransAeris® Diaphragm Pacing System during the COVID-19 pandemic, which received an Emergency Use Authorization from the Food and Drug Administration on April 13, 2020. The TransAeris® Diaphragm Pacing System is authorized for use in healthcare settings to assist in weaning patients determined by their healthcare provider to be at high risk of weaning failure off ventilators, for no more than 30 days.

Loading Wayback Capture Info...

Loading video data...

Title: Fact Sheet for Healthcare Providers: Emergency Use of the CytoSorb Device for COVID-19

URL: https://www.fda.gov/media/136864/download

Collection: Global Health Events web archive

Description: This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the CytoSorb device for the reduction of pro-inflammatory cytokine levels, which received an Emergency Use Authorization from the Food and Drug Administration on April 10, 2020. The CytoSorb device is authorized for emergency use to treat patients 18 years of age or older with confirmed COVID-19 admitted to the intensive care unit (ICU) with confirmed or imminent respiratory failure.

Loading Wayback Capture Info...

Loading video data...

Title: Fact Sheet for Healthcare Providers: Emergency Use of Ventilators During the COVID-19 Pandemic

URL: https://www.fda.gov/media/136424/download

Collection: Global Health Events web archive

Description: This two-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of ventilators, anesthesia gas machines modified for use as ventilators, and positive pressure breathing devices modified for use as ventilators (collectively referred to as "ventilators"), ventilator tubing connectors, and ventilator accessories that are authorized for emergency use in healthcare settings for treatment of patients during the COVID-19 pandemic by their healthcare providers.

Loading Wayback Capture Info...

Loading video data...

Title: Fact Sheet for Healthcare Providers: Emergency Use of Spectra Optia Apheresis System with the Depuro D2000 Adsorption Cartridge for COVID-19

URL: https://www.fda.gov/media/136836/download

Collection: Global Health Events web archive

Description: This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Spectra Optia Apheresis System with the Depuro D2000 Adsorption Cartridge for the reduction of pro-inflammatory cytokine levels, which received an Emergency Use Authorization from the Food and Drug Administration on April 9, 2020. The Spectra Optia Apheresis System with the Depuro D2000 Adsorption Cartridge is authorized for emergency use to treat patients 18 years of age or older with confirmed COVID-19 admitted to the intensive care unit (ICU) with confirmed or imminent respiratory failure.

Loading Wayback Capture Info...

Loading video data...

Title: Fact Sheet for Healthcare Providers: Emergency Use of Seraph 100 Microbind Affinity Blood Filter for COVID-19

URL: https://www.fda.gov/media/137102/download

Collection: Global Health Events web archive

Description: This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Seraph 100 Microbind Affinity Blood Filter device for the reduction of pathogens and inflammatory mediators. The Seraph 100 Microbind Affinity Blood Filter device was authorized for emergency use by the Food and Drug Administration on April 17, 2020, to treat patients 18 years of age or older with confirmed COVID-19 admitted to the intensive care unit (ICU) with confirmed or imminent respiratory failure.

Loading Wayback Capture Info...

Loading video data...

Title: Fact Sheet for Healthcare Providers: Emergency Use of Philips IntelliVue Patient Monitors MX750 and MX850, Philips IntelliVue 4-Slot Module Rack FMX-4, and Philips IntelliVue Active Displays AD75 and AD85 During the COVID-19 Pandemic

URL: https://www.fda.gov/media/137227/download

Collection: Global Health Events web archive

Description: This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Philips IntelliVue Patient Monitors MX750 and MX850; Philips IntelliVue 4-Slot Module Rack FMX-4; and Philips IntelliVue Active Displays AD75 and AD85, which received an Emergency Use Authorization from the Food and Drug Administration on April 22, 2020. These devices are authorized for emergency use by healthcare professionals in the hospital environment for the monitoring of patients having or suspected of having COVID-19, to reduce healthcare provider exposure to COVID-19.

Loading Wayback Capture Info...

Loading video data...

Title: FDA warns consumers about fraudulent Ebola treatment products

URL: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm410086.htm

Collection: Global Health Events web archive

Description: Press release titled, "FDA warns consumers about fraudulent Ebola treatment protocols," published on the Food and Drug Administration (FDA) website on August 14, 2014. The statement provides factual information regarding Ebola treatments.

Loading Wayback Capture Info...

Loading video data...

Title: Enforcement Policy for Remote Ophthalmic Assessment and Monitoring Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency | FDA

URL: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-remote-ophthalmic-assessment-and-monitoring-devices-during-coronavirus-disease

Collection: Global Health Events web archive

Description: This 11-page guidance provides a policy to help expand the capability of remote ophthalmic assessment and monitoring devices to facilitate patient care while reducing patient and healthcare provider contact and exposure to COVID-19 during the COVID-19 pandemic.

Loading Wayback Capture Info...

Loading video data...

Title: Coronavirus Disease 2019 (COVID-19) Resources for Patients | FDA

URL: https://www.fda.gov/patients/coronavirus-disease-2019-covid-19-resources-patients/

Collection: Global Health Events web archive

Description: US Food and Drug Administration web page of coronavirus resources for patients. Includes information on hand sanitizers, testing and treatment options, donating blood and plasma, fake products, medical product shortages, clinical trials, food safety, and the expanded access program.

Loading Wayback Capture Info...

Loading video data...

Title: Coronavirus (COVID-19) Update: Federal judge enters temporary injunction against Genesis II Church of Health and Healing, preventing sale of Chlorine Dioxide Products Equivalent to Industrial Bleach to Treat COVID-19 | FDA

URL: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-federal-judge-enters-temporary-injunction-against-genesis-ii-church

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Title: Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Monoclonal Antibody Bamlanivimab | FDA

URL: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-monoclonal-antibody-bamlanivimab/

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Title: Coronavirus (COVID-19) Update: FDA Provides Updated Guidance to Address the Urgent Need for Blood During the Pandemic | FDA

URL: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-provides-updated-guidance-address-urgent-need-blood-during-pandemic/

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Title: Coronavirus (COVID-19) Update: FDA Provides Updated Guidance to Address the Urgent Need for Blood During the Pandemic | FDA

URL: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-provides-updated-guidance-address-urgent-need-blood-during-pandemic

Collection: Global Health Events web archive

Description: This web page provides guidance for immediate implementation to address the urgent and immediate need for blood and blood components during the COVID-19 pandemic. The FDA has concluded that current policies regarding certain donor eligibility criteria can be modified without compromising the safety of the blood supply.

Loading Wayback Capture Info...

Loading video data...

Title: Coronavirus (COVID-19) Update: FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant | FDA

URL: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-limits-use-certain-monoclonal-antibodies-treat-covid-19-due-omicron

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Title: Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibody for Treatment of COVID-19 | FDA

URL: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibody-treatment-covid-19/

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Title: Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19 | FDA

URL: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibodies-treatment-covid-19-0/

Collection: Global Health Events web archive

Loading Wayback Capture Info...

Loading video data...

Title: Brote de la enfermedad del Ébola en África Occidental de 2014

URL: http://www.fda.gov/EmergencyPreparedness/Counterterrorism/MedicalCountermeasures/ucm411643.htm

Collection: Global Health Events web archive

Description: Page on the US Food and Drug Administration (USDA) website featuring the most recent updates on the Ebola response at the Food and Drug Administration (FDA) in Spanish. The FDA is working to expedite the development and availability of medical products, including treatments, vaccines, diagnostic tests, and personal protective equipment, that may help to end the Ebola epidemic in West Africa.

Loading Wayback Capture Info...

Loading video data...

Title: Beware of Fraudulent Coronavirus Tests, Vaccines and Treatments | FDA

URL: https://www.fda.gov/consumers/consumer-updates/beware-fraudulent-coronavirus-tests-vaccines-and-treatments/

Collection: Global Health Events web archive

Description: Website from U.S. Food and Drug Administration regarding fraudulent COVID-19 tests, vaccines and treatments

Loading Wayback Capture Info...

Loading video data...

Page 1 of 1 (27 Total Results)